Point of Care Significance 6/10

Dual-probe RT-LAMP assay enables rapid subtype-specific detection of RSV A and B

Investigators developed and clinically evaluated a multiplex dual-probe RT-LAMP assay designed to differentiate respiratory syncytial virus subtypes A and B. The study reports that testing against 91 RSV A-positive, 97 RSV B-positive, and 120 RSV-negative clinical specimens yielded sensitivities of 92.31% and 98.97%, respectively, with 100% specificity for both targets and no cross-reactivity with common respiratory pathogens. The assay operates under isothermal conditions without complex instrumentation, offering a rapid, subtype-resolved alternative to RT-qPCR that could support decentralized testing environments, though independent validation remains necessary before clinical deployment.

The original study

A multiplex dual-probe RT-LAMP assay for rapid subtype-specific detection of respiratory syncytial virus A and B.

Authors
Lim MS, Park C, Lee E, Ko SY, Jang WS
Journal
PloS one
Type
Journal Article
PMID
42536630
Read the original study →

Original abstract

Respiratory syncytial virus (RSV) is a leading cause of acute respiratory tract infections, particularly in infants, older adults, and immunocompromised individuals. RSV is classified into two major subtypes, RSV A and RSV B, which co-circulate seasonally and exhibit genetic variability, highlighting the need for rapid and subtype-specific diagnostic methods. Although reverse transcription quantitative PCR (RT-qPCR) is the reference standard for RSV detection, its reliance on complex instrumentation limits its applicability in decentralized testing settings. In this study, we developed and evaluated a probe-based reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for rapid detection and differentiation of RSV A and RSV B. The assay incorporates a dual-probe strategy, employing an assimilating probe for RSV A detection to ensure robust signal generation under multiplex conditions, and hybridization-based TaqMan-style probes (HyTaq probes) for RSV B detection and for an internal control targeting the human ACTB gene to ensure reaction validity. Analytical performance was assessed using serially diluted RSV positive clinical specimens and plasmid standards. Clinical performance was evaluated using 91 RSV A positive specimens, 97 RSV B positive specimens, and 120 RSV negative specimens, as defined by the reference diagnosis. The RSV A and RSV B RT-LAMP assays demonstrated sensitivities of 92.31% and 98.97%, respectively, with a specificity of 100% for both targets. No cross-reactivity was observed with a panel of common respiratory viruses. These results indicate that the proposed dual-probe RT-LAMP assay provides a rapid and specific approach for subtype-specific RSV detection, with potential applicability in decentralized diagnostic settings pending further validation.